Joint Statement on clinical selection for Trans-catheter Aortic Valve Implantation (TAVI)
Intervention for aortic stenosis is evolving rapidly. Trans-catheter aortic valve implantation is a minimally invasive alternative to surgical aortic valve replacement. The evidence base for use of TAVI as an alternative to either medical therapy or SAVR has expanded. This statement summarises the views of the British Cardiovascular Society, Society for Cardiothoracic Surgery, and the British Cardiovascular Intervention Society on how patients with aortic valve disease should be treated and which patients are best suited to TAVI, on the basis of current evidence.